Parties d'ouvrages collectifs (6)

  1. 1. Ausiello, C. M., Mascart, F., Corbiere, V., & Fedele, G. (2019). Human Immune Responses to Pertussis Vaccines. In Pertussis Infection and Vaccines.: Advances in Experimental Medicine and Biology (1 ed., pp. pp 99-113). Springer, Cham.
  2. 2. Mascart, F., Dirix, V., & Locht, C. (2019). The human immune responses to pertussis and pertussis vaccines. In Pertussis: epidemiology, immunology, and evolution (pp. 112-132). Pejman Rohani and Samuel V. Scarpino.(Oxford University Press).
  3. 3. Desmet, R., Diesis, E., Drobecq, H., Rouanet, C., Chemlal, K., Debrie, A.-S., Hougardy, J.-M., Mascart, F., Locht, C., & Melnyk, O. (2010). In situ chemical modification of peptide microarrays.: Application to the study of the antibody responses to methylated antigens. In M. Uttamchandani & S. Yao (Eds.), Methods in Molecular Biology: Small Molecule Mircoarrays: Methods and Protocols (pp. 135-45). Humana Press/Springer.
  4. 4. Locht, C., Raze, D., Rouanet, C., Genisset, C., Segers, J., & Mascart, F. (2008). The mycobacterial heparin-binding hemagglutinin, virulence factor and antigen useful for diagnostics and vaccine development. In M. Daffe & J. Reyrat (Eds.), The Mycobacterial Cell Envelope (pp. 305-322). Washington DC: ASM Press.
  5. 5. Locht, C., Mascart, F., & Rouanet, C. (2006). Un nouveau regard sur la tuberculose latente et la réactivation, implications pour le diagnostic et la vaccination. In J.-F. Nicolas & J. Thivolet (Eds.), Immunologie clinique et allergologie. Allergie aux médicaments. Tests immuno-biologiques (pp. 11-16). John Libbey Eurotext.
  6. 6. Schandené, L., Ferster, A., Mascart, F., Goetghebuer, T., Marchant, A., Velu, T., Sariban, E., & Goldman, M. (1992). Imbalance in the production of interferon-gamma and interleukin-4 in a patient with Ommen's syndrome: rationale for interferon-gamma therapy. In New Advances on Cytokines (pp. 219-225). Raven Press.(Serono symposia publication).
  7.   Articles dans des revues avec comité de lecture (193)

  8. 1. Lavis, P., Morra, S., Orte Cano, C., Albayrak, N., Corbiere, V., Olislagers, V., Dauby, N., Del Marmol, V., Marchant, A., Decaestecker, C., Mascart, F., De Vos, N., Van De Borne, P., Salmon, I., Remmelink, M., Parmentier, M., Cardozo, A. K., & Bondue, B. (2022). Chemerin plasma levels are increased in COVID-19 patients and are an independent risk factor of mortality. Frontiers in immunology, 13, 941663. doi:10.3389/fimmu.2022.941663
  9. 2. Dirix, V., Dauby, N., Hites, M., Watelet, E., Van Praet, A., Godefroid, A., Petit, E., Singh, M., Locht, C., Mascart, F., & Corbiere, V. (2022). Optimal Detection of Latent Mycobacterium tuberculosis Infection by Combined Heparin-Binding Hemagglutinin (HBHA) and Early Secreted Antigenic Target 6 (ESAT-6) Whole-Blood Interferon Gamma Release Assays. Journal of clinical microbiology, 60(5), e0244321. doi:10.1128/jcm.02443-21
  10. 3. Albayrak, N., Orte Cano, C., Karimi, S., Dogahe, D., Van Praet, A., Godefroid, A., Del Marmol, V., Grimaldi, D., Bondue, B., Van Vooren, J.-P., Mascart, F., & Corbiere, V. (2022). Distinct Expression Patterns of Interleukin-22 Receptor 1 on Blood Hematopoietic Cells in SARS-CoV-2 Infection. Frontiers in Immunology, 13. doi:10.3389/fimmu.2022.769839
  11. 4. Dirix, V., Collart, P., Van Praet, A., Hites, M., Dauby, N., Allard, S., Racapé, J., Singh, M., Locht, C., Mascart, F., & Corbiere, V. (2022). Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country. Frontiers in immunology, 13, 842604. doi:10.3389/fimmu.2022.842604
  12. 5. Benhadou, F., Dirix, V., Domont, F., Willaert, F., Van Praet, A., Locht, C., Mascart, F., & Corbiere, V. (2021). Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment. Frontiers in immunology, 12, 672894. doi:10.3389/fimmu.2021.672894
  13. 6. Albayrak, N., Dirix, V., Aerts, L., Van Praet, A., Godefroid, A., Dauby, N., Windey, P., Muylle, I., Mascart, F., & Corbiere, V. (2021). Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosis. Journal of leukocyte biology. doi:10.1002/JLB.4A1020-641RR

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 Suivant >>